Showing results 9046 to 9065 of 14621
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 2016 | n-3 fatty acid supplementation and leukocyte telomere length in patients with chronic kidney disease | Barden, A.; O Callaghan, N.; Burke, V.; Mas, E.; Beilin, L.J.; Fenech, M.; Irish, A.B.; Watts, G.F.; Puddey, I.B.; Huang, R.C.; Mori, T.A. |
| 2015 | N-3 fatty acids reduce plasma 20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease | Barden, A.; Burke, V.; Mas, E.; Beilin, L.; Puddey, I.; Watts, G.; Irish, A.; Mori, T. |
| 1996 | N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock | Peake, S.; Moran, J.; Leppard, P. |
| 2016 | N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms | Rossell, S.; Francis, P.; Galletly, C.; Harris, A.; Siskind, D.; Berk, M.; Bozaoglu, K.; Dark, F.; Dean, O.; Liu, D.; Meyer, D.; Neill, E.; Phillipou, A.; Sarris, J.; Castle, D. |
| 2022 | N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms | Neill, E.; Rossell, S.L.; Yolland, C.; Meyer, D.; Galletly, C.; Harris, A.; Siskind, D.; Berk, M.; Bozaoglu, K.; Dark, F.; Dean, O.M.; Francis, P.S.; Liu, D.; Phillipou, A.; Sarris, J.; Castle, D.J. |
| 1995 | N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction | Arstall, M.; Yang, J.; Stafford, I.; Betts, W.; Horowitz, J. |
| 1996 | N-acetylcysteine potentiates nitroglycerin-induced reversal of platelet aggregation. | Chirkov, Y.; Horowitz, J. |
| 2019 | N-acetylcysteine reverses peroxynitrite and hydrogen peroxide-induced apoptosis of human myocardial cells | Liu, S.; Horowitz, J.; 68th Annual Scientific Session and Expo of the American College of Cardiology (ACC) (16 Mar 2019 - 18 Mar 2019 : New Orleans, LA) |
| 2016 | N-glycan MALDI imaging mass spectrometry on formalin-fixed paraffin-embedded tissue enables the delineation of ovarian cancer tissues | Everest-Dass, A.; Briggs, M.; Kaur, G.; Oehler, M.; Hoffmann, P.; Packer, N. |
| 2013 | N-terminal B-type natriuretic peptide and the association with left ventricular diastolic function in a population at high risk of incident heart failure: Results of the SCReening Evaluation of the Evolution of New-Heart Failure Study (SCREEN-HF) | McGrady, M.; Reid, C.M.; Shiel, L.; Wolfe, R.; Boffa, U.; Liew, D.; Campbell, D.J.; Prior, D.; Krum, H. |
| 2013 | N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: Insights from the aristotle trial (apixaban for the prevention of stroke in subjects with atrial fibrillation) | Hijazi, Z.; Wallentin, L.; Siegbahn, A.; Andersson, U.; Christersson, C.; Ezekowitz, J.; Gersh, B.; Hanna, M.; Hohnloser, S.; Horowitz, J.; Huber, K.; Hylek, E.; Lopes, R.; McMurray, J.; Granger, C. |
| 2012 | N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis | Thakkar, V.; Stevens, W.; Prior, D.; Moore, O.; Byron, J.; Patterson, K.; Hissaria, P.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Celermajer, D.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.; ARA-RHPA 53rd Annual Scientific Meeting (12 May 2012 - 15 May 2012 : Canberra, ACT) |
| 2013 | N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis | Thakkar, V.; Stevens, W.; Prior, D.; Moore, O.; Byron, J.; Patterson, K.; Hissaria, P.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Celermajer, D.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.; Australian Scleroderma Interest Group,; 2012 Annual European Congress of Rheumatology (EULAR) (6 Jun 2012 - 9 Jun 2012 : Berlin, Germany) |
| 2012 | N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study | Thakkar, V.; Stevens, W.; Prior, D.; Moore, O.; Byron, J.; Liew, D.; Patterson, K.; Hissaria, P.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Celermajer, D.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M. |
| 2012 | N-terminal pro-brain natriuretic peptide levels predict incident pulmonary arterial hypertension in SSc | Thakkar, V.; Stevens, W.; Prior, D.; Byron, J.; Patterson, K.; Hissaria, P.; Moore, O.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Youssef, P.; Proudman, S.; Nikpour, M.; 2nd Systemic Sclerosis World Congress (2 Feb 2012 - 4 Feb 2012 : Madrid, Spain) |
| 2011 | N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy | Nguyen, T.; Neil, C.; Sverdlov, A.; Mahadevan, G.; Chirkov, Y.; Kucia, A.; Stansborough, J.; Beltrame, J.; Selvanayagam, J.; Zeitz, C.; Struthers, A.; Frenneaux, M.; Horowitz, J. |
| 2002 | N4WBP5, a potential target for ubiquitination by the Nedd4 family of proteins, is a novel golgi-associated protein | Harvey, K.; Shearwin-Whyatt, L.; Fotia, A.; Parton, R.; Kumar, S. |
| 2004 | N4WBP5A (Ndfip2), a Nedd4-interacting protein, localizes to multivesicular bodies and the Golgi, and has a potential role in protein trafficking | Shearwin-Whyatt, L.; Brown, D.; Wylie, F.; Stow, J.; Kumar, S. |
| 1999 | Na+-H+ exchange in salivary secretory cells is controlled by an intracellular Na+ receptor | Ishibashi, H.; Dinudom, A.; Harvey, K.; Kumar, S.; Young, J.; Cook, D. |
| 2008 | Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system | Na, S.Y.; Cao, Y.; Toben, C.; Nitschke, L.; Stadelmann, C.; Gold, R.; Schimpl, A.; Hunig, T. |
